Welcome to CDC Stacks | Multidrug-resistant tuberculosis; (MDR TB) - 5883 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Multidrug-resistant tuberculosis; (MDR TB)
  • Published Date:
    April 2010
Filetype[PDF - 279.19 KB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
  • Series:
    TB elimination
  • Description:
    "Multidrug-resistant TB (MDR TB) is TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. These drugs are considered first-line drugs and are used to treat all persons with TB disease." - p. 1

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Place as Subject:
    United States
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Multidrug-resistant tuberculosis; (MDR TB)
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published:
    May 2012
    Series:
    TB elimination
    Description:
    Tuberculosis (TB) is a disease caused by bacteria that are spread from person to person through the air. TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. In most cases, TB is ...
    File Type:
    Filetype[PDF - 380.91 KB]
  2. Investigation of international traveler with multidrug-resistant tuberculosis (MDR TB)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    12/29/07
    Source:
    HAN ; 267
    Series:
    HAN ; 267
    Description:
    Saturday, December 29, 2007, 19:35 EST (07:35 PM EST) : CDCHAN-00267-2007-12-29-ADV-N : The Centers for Disease Control and Prevention (CDC) is working with international, state, and local health officials and other partners on an investigation invol...
    File Type:
    Filetype[PDF - 31.87 KB]
  3. Multidrug-Resistant Tuberculosis
    Personal Author:
    D’Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni B.;
    Published:
    Nov 29 2012
    Source:
    N Engl J Med. 367(22):2154-2156.
    File Type:
    Filetype[PDF - 32.34 KB]
  4. Multidrug-resistant Tuberculosis Detection, Latvia
    Personal Author:
    Skenders, Girts; Fry, Alicia M.; Prokopovica, Inga; Greckoseja, Silvija; Broka, Lonija; Metchock, Beverly; Holtz, Timothy H.; Wells, Charles D.; Leimane, Vaira;
    Published:
    Sep 2005
    Source:
    Emerg Infect Dis. 11(9):1461-1463.
    Description:
    To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91%...
    File Type:
    Filetype[PDF - 52.80 KB]
  5. Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
    Personal Author:
    de Steenwinkel, Jurriaan E.M.; ten Kate, Marian T.; de Knegt, Gerjo J.; Kremer, Kristin; Aarnoutse, Rob E.; Boeree, Martin J.; Verbrugh, Henri A.; van Soolingen, Dick; Bakker-Woudenberg, Irma A.J.M.;
    Published:
    Apr 2012
    Source:
    Emerg Infect Dis. 18(4):660-663.
    Description:
    To determine differences in the ability of Mycobacterium tuberculosis strains to withstand antituberculosis drug treatment, we compared the activity of antituberculosis drugs against susceptible Beijing and East-African/Indian genotype M. tuberculosi...
    File Type:
    Filetype[PDF - 378.24 KB]